Bleomycin and pulmonary toxicity.
P W
PW
Van Barneveld
N H
NH
Mulder
T W
TW
Van der Mark
D T
DT
Sleijfer
D000368:Aged; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage; D001761:Bleomycin / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D001980:Bronchi / Q000473:pathology; D006224:Cricetinae; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D051379:Mice; D010215:Papio; D011650:Pulmonary Alveoli / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000503:physiopathology; D011817:Rabbits; D051381:Rats; D012129:Respiratory Function Tests; D012306:Risk
D000975:Antioxidants; D001761:Bleomycin